All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses

Paediatric Respiratory Reviews

Volumn 23, Issue , 2017, Pages 40-49

  Oczypok, Elizabeth A ^a   Perkins, Timothy N ^a   Oury, Tim D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Bronchopulmonary dysplasia; Cystic fibrosis; Pulmonary disease; Receptor for advanced glycation endproducts (RAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN; CALGRANULIN C; CALVASCULIN; HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC AIRWAY INFLAMMATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG PARENCHYMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; ADULT; ANTAGONISTS AND INHIBITORS; CHILD; DRUG DEVELOPMENT; METABOLISM;

ADULT; CHILD; DRUG DISCOVERY; GLYCATION END PRODUCTS, ADVANCED; HUMANS; PNEUMONIA; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS;

EID: 85017465805     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2017.03.012     Document Type: Review

References (151)

1. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:Jul (21) (1992), 14998–15004 PubMed PMID: 1378843.
2. Yonekura, H., Yamamoto, Y., Sakurai, S., Petrova, R.G., Abedin, M.J., Li, H., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:Mar (Pt 3) (2003), 1097–1109 PubMed PMID: 12495433. Pubmed Central PMCID: 1223244.
3. Harashima, A., Yamamoto, Y., Cheng, C., Tsuneyama, K., Myint, K.M., Takeuchi, A., et al. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem J 396:May (1) (2006), 109–115 PubMed PMID: 16503878. Pubmed Central PMCID: 1450004.
4. Hanford, L.E., Enghild, J.J., Valnickova, Z., Petersen, S.V., Schaefer, L.M., Schaefer, T.M., et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279:Nov (48) (2004), 50019–50024 PubMed PMID: 15381690. Pubmed Central PMCID: 1868562.
5. Raucci, A., Cugusi, S., Antonelli, A., Barabino, S.M., Monti, L., Bierhaus, A., et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22:Oct (10) (2008), 3716–3727 PubMed PMID: 18603587.
6. Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V.V., Fahrenholz, F., et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 283:Dec (51) (2008), 35507–35516 PubMed PMID: 18952609.
7. Hudson, B.I., Carter, A.M., Harja, E., Kalea, A.Z., Arriero, M., Yang, H., et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J 22:May (5) (2008), 1572–1580 PubMed PMID: 18089847.
8. Gefter, J.V., Shaufl, A.L., Fink, M.P., Delude, R.L., Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines. Cell Tissue Res 337:Jul (1) (2009), 79–89 PubMed PMID: 19415334.
9. Kalea, A.Z., Reiniger, N., Yang, H., Arriero, M., Schmidt, A.M., Hudson, B.I., Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J 23:Jun (6) (2009), 1766–1774 PubMed PMID: 19164451. Pubmed Central PMCID: 2698653.
10. Bierhaus, A., Humpert, P.M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., et al. Understanding RAGE, the receptor for advanced glycation end products. Journal of molecular medicine 83:Nov (11) (2005), 876–886 PubMed PMID: 16133426.
11. Brett, J., Schmidt, A.M., Yan, S.D., Zou, Y.S., Weidman, E., Pinsky, D., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:Dec (6) (1993), 1699–1712 PubMed PMID: 8256857. Pubmed Central PMCID: 1887265.
12. Katsuoka, F., Kawakami, Y., Arai, T., Imuta, H., Fujiwara, M., Kanma, H., et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 238:Sep (2) (1997), 512–516 PubMed PMID: 9299542.
13. Englert, J.M., Hanford, L.E., Kaminski, N., Tobolewski, J.M., Tan, R.J., Fattman, C.L., et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172:Mar (3) (2008), 583–591 PubMed PMID: 18245812. Pubmed Central PMCID: 2258251.
14. Hanford, L.E., Fattman, C.L., Shaefer, L.M., Enghild, J.J., Valnickova, Z., Oury, T.D., Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am J Respir Cell Mol Biol 29:Sep (3 Suppl) (2003), S77–S81 PubMed PMID: 14503560.
15. Fehrenbach, H., Kasper, M., Tschernig, T., Shearman, M.S., Schuh, D., Muller, M., Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) 44:Nov (7) (1998), 1147–1157 PubMed PMID: 9846897.
16. Dahlin, K., Mager, E.M., Allen, L., Tigue, Z., Goodglick, L., Wadehra, M., et al. Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 31:Sep (3) (2004), 309–316 PubMed PMID: 15205179.
17. Shirasawa, M., Fujiwara, N., Hirabayashi, S., Ohno, H., Iida, J., Makita, K., et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes to cells: devoted to molecular & cellular mechanisms 9:Feb (2) (2004), 165–174 PubMed PMID: 15009093.
18. Uchida, T., Shirasawa, M., Ware, L.B., Kojima, K., Hata, Y., Makita, K., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 173:May (9) (2006), 1008–1015 PubMed PMID: 16456142. Pubmed Central PMCID: 2662912.
19. Ferhani, N., Letuve, S., Kozhich, A., Thibaudeau, O., Grandsaigne, M., Maret, M., et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:May (9) (2010), 917–927 PubMed PMID: 20133931.
20. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270:Oct (43) (1995), 25752–25761 PubMed PMID: 7592757.
21. Dumitriu, I.E., Baruah, P., Valentinis, B., Voll, R.E., Herrmann, M., Nawroth, P.P., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174:Jun (12) (2005), 7506–7515 PubMed PMID: 15944249.
22. Curran, C.S., Bertics, P.J., Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. International immunology 23:Dec (12) (2011), 713–728 PubMed PMID: 22025532. Pubmed Central PMCID: 3226529.
23. Chen, Y., Yan, S.S., Colgan, J., Zhang, H.P., Luban, J., Schmidt, A.M., et al. Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173:Jul (2) (2004), 1399–1405 PubMed PMID: 15240736.
24. Chen, Y., Akirav, E.M., Chen, W., Henegariu, O., Moser, B., Desai, D., et al. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 181:Sep (6) (2008), 4272–4278 PubMed PMID: 18768885. Pubmed Central PMCID: 2643976.
25. Moser, B., Desai, D.D., Downie, M.P., Chen, Y., Yan, S.F., Herold, K., et al. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol 179:Dec (12) (2007), 8051–8058 PubMed PMID: 18056345.
26. Akirav, E.M., Preston-Hurlburt, P., Garyu, J., Henegariu, O., Clynes, R., Schmidt, A.M., et al. RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One, 7(4), 2012, e34698 PubMed PMID: 22509345. Pubmed Central PMCID: 3324532.
27. Schmidt, A.M., Yan, S.D., Yan, S.F., Stern, D.M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:Oct (7) (2001), 949–955 PubMed PMID: 11581294. Pubmed Central PMCID: 200958.
28. Bartling, B., Hofmann, H.S., Weigle, B., Silber, R.E., Simm, A., Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26:Feb (2) (2005), 293–301 PubMed PMID: 15539404.
29. Lin, L., RAGE on the Toll Road?. Cellular & molecular immunology 3:Oct (5) (2006), 351–358 PubMed PMID: 17092432.
30. Srikrishna, G., Freeze, H.H., Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11:Jul (7) (2009), 615–628 PubMed PMID: 19568407. Pubmed Central PMCID: 2697348.
31. Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D.S., Shekhtman, A., Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283:Oct (40) (2008), 27255–27269 PubMed PMID: 18667420.
32. Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., Aldini, G., Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47:Aug (Suppl 1) (2013), 3–27 PubMed PMID: 23767955.
33. Hofmann, M.A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:Jun (7) (1999), 889–901 PubMed PMID: 10399917.
34. Leclerc, E., Fritz, G., Vetter, S.W., Heizmann, C.W., Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793:Jun (6) (2009), 993–1007 PubMed PMID: 19121341.
35. Meloche, J., Courchesne, A., Barrier, M., Carter, S., Bisserier, M., Paulin, R., et al. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. Journal of the American Heart Association, 2(1), 2013, e005157 PubMed PMID: 23525442. Pubmed Central PMCID: 3603259.
36. Kang, J.H., Hwang, S.M., Chung, I.Y., S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-kappaB pathways. Immunology 144:Jan (1) (2015), 79–90 PubMed PMID: 24975020. Pubmed Central PMCID: 4264912.
37. Jin, S., Park, C.O., Shin, J.U., Noh, J.Y., Lee, Y.S., Lee, N.R., et al. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Experimental dermatology 23:Dec (12) (2014), 938–941 PubMed PMID: 25308296.
38. Scaffidi, P., Misteli, T., Bianchi, M.E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:Jul (6894) (2002), 191–195 PubMed PMID: 12110890.
39. Li, G., Liang, X., Lotze, M.T., HMGB1: The Central Cytokine for All Lymphoid Cells. Frontiers in immunology, 4, 2013, 68 PubMed PMID: 23519706. Pubmed Central PMCID: 3602962.
40. Lotze, M.T., Tracey, K.J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:Apr (4) (2005), 331–342 PubMed PMID: 15803152.
41. Milutinovic, P.S., Englert, J.M., Crum, L.T., Mason, N.S., Ramsgaard, L., Enghild, J.J., et al. Clearance Kinetics and Matrix Binding Partners of the Receptor for Advanced Glycation End Products. PLoS One, 9(3), 2014, e88259 PubMed PMID: 24642901.
42. Demling, N., Ehrhardt, C., Kasper, M., Laue, M., Knels, L., Rieber, E.P., Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 323:Mar (3) (2006), 475–488 PubMed PMID: 16315007.
43. Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:Aug (6593) (1996), 685–691 PubMed PMID: 8751438.
44. Deane, R., Du Yan, S., Submamaryan, R.K., LaRue, B., Jovanovic, S., Hogg, E., et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:Jul (7) (2003), 907–913 PubMed PMID: 12808450.
45. Park, H., Adsit, F.G., Boyington, J.C., The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem 285:Dec (52) (2010), 40762–40770 PubMed PMID: 20943659. Pubmed Central PMCID: 3003376.
46. Sirois, C.M., Jin, T., Miller, A.L., Bertheloot, D., Nakamura, H., Horvath, G.L., et al. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J Exp Med 210:Oct (11) (2013), 2447–2463 PubMed PMID: 24081950. Pubmed Central PMCID: 3804942.
47. Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198:Nov (10) (2003), 1507–1515 PubMed PMID: 14623906. Pubmed Central PMCID: 2194124.
48. Li, J., Schmidt, A.M., Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272:Jun (26) (1997), 16498–16506 PubMed PMID: 9195959.
49. Li, J., Qu, X., Schmidt, A.M., Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem 273:Nov (47) (1998), 30870–30878 PubMed PMID: 9812979.
50. Tanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., Yamamoto, H., The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275:Aug (33) (2000), 25781–25790 PubMed PMID: 10829018.
51. Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P.M., Chen, J., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:Dec (12) (2001), 2792–2808 PubMed PMID: 11723063.
52. Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:Apr (13) (1994), 9889–9897 PubMed PMID: 8144582.
53. Basta, G., Lazzerini, G., Del Turco, S., Ratto, G.M., Schmidt, A.M., De Caterina, R., At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25:Jul (7) (2005), 1401–1407 PubMed PMID: 15845907.
54. Vincent, A.M., Perrone, L., Sullivan, K.A., Backus, C., Sastry, A.M., Lastoskie, C., et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148:Feb (2) (2007), 548–558 PubMed PMID: 17095586.
55. Lander, H.M., Tauras, J.M., Ogiste, J.S., Hori, O., Moss, R.A., Schmidt, A.M., Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:Jul (28) (1997), 17810–17814 PubMed PMID: 9211935.
56. Yeh, C.H., Sturgis, L., Haidacher, J., Zhang, X.N., Sherwood, S.J., Bjercke, R.J., et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 50:Jun (6) (2001), 1495–1504 PubMed PMID: 11375353.
57. Huttunen, H.J., Fages, C., Rauvala, H., Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274:Jul (28) (1999), 19919–19924 PubMed PMID: 10391939.
58. Hudson, B.I., Kalea, A.Z., Del Mar Arriero, M., Harja, E., Boulanger, E., D'Agati, V., et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283:Dec (49) (2008), 34457–34468 PubMed PMID: 18922799. Pubmed Central PMCID: 2590709.
59. Huang, J.S., Guh, J.Y., Chen, H.C., Hung, W.C., Lai, Y.H., Chuang, L.Y., Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. Journal of cellular biochemistry 81:1 (2001), 102–113 PubMed PMID: 11180401.
60. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., Kasaoka, T., The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 550:Aug (1–3) (2003), 107–113 PubMed PMID: 12935895.
61. Sessa, L., Gatti, E., Zeni, F., Antonelli, A., Catucci, A., Koch, M., et al. The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs). PLoS One, 9(1), 2014, e86903 PubMed PMID: 24475194. Pubmed Central PMCID: 3903589.
62. Frommhold, D., Kamphues, A., Hepper, I., Pruenster, M., Lukic, I.K., Socher, I., et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 116:Aug (5) (2010), 841–849 PubMed PMID: 20407037.
63. Frommhold, D., Kamphues, A., Dannenberg, S., Buschmann, K., Zablotskaya, V., Tschada, R., et al. RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner. BMC immunology, 12, 2011, 56 PubMed PMID: 21970746. Pubmed Central PMCID: 3203087.
64. Buschmann, K., Tschada, R., Metzger, M.S., Braach, N., Kuss, N., Hudalla, H., et al. RAGE controls leukocyte adhesion in preterm and term infants. BMC immunology, 15(Nov (1)), 2014, 53 PubMed PMID: 25428166. Pubmed Central PMCID: 4256735.
65. Schmidt, A.M., Hori, O., Chen, J.X., Li, J.F., Crandall, J., Zhang, J., et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:Sep (3) (1995), 1395–1403 PubMed PMID: 7544803. Pubmed Central PMCID: 185762.
66. Boulanger, E., Wautier, M.P., Wautier, J.L., Boval, B., Panis, Y., Wernert, N., et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney international 61:Jan (1) (2002), 148–156 PubMed PMID: 11786095.
67. Liliensiek, B., Weigand, M.A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113:Jun (11) (2004), 1641–1650 PubMed PMID: 15173891. Pubmed Central PMCID: 419481.
68. Moser, B., Szabolcs, M.J., Ankersmit, H.J., Lu, Y., Qu, W., Weinberg, A., et al. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7:Feb (2) (2007), 293–302 PubMed PMID: 17241110.
69. Manfredi, A.A., Capobianco, A., Esposito, A., De Cobelli, F., Canu, T., Monno, A., et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 180:Feb (4) (2008), 2270–2275 PubMed PMID: 18250435.
70. Repapi, E., Sayers, I., Wain, L.V., Burton, P.R., Johnson, T., Obeidat, M., et al. Genome-wide association study identifies five loci associated with lung function. Nature genetics 42:Jan (1) (2010), 36–44 PubMed PMID: 20010834. Pubmed Central PMCID: 2862965.
71. Hancock, D.B., Eijgelsheim, M., Wilk, J.B., Gharib, S.A., Loehr, L.R., Marciante, K.D., et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nature genetics 42:Jan (1) (2010), 45–52 PubMed PMID: 20010835. Pubmed Central PMCID: 2832852.
72. Hofmann, M.A., Drury, S., Hudson, B.I., Gleason, M.R., Qu, W., Lu, Y., et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and immunity 3:May (3) (2002), 123–135 PubMed PMID: 12070776.
73. Osawa, M., Yamamoto, Y., Munesue, S., Murakami, N., Sakurai, S., Watanabe, T., et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim Biophys Acta 1770:Oct (10) (2007), 1468–1474 PubMed PMID: 17714874.
74. Watanabe, T., Asai, K., Fujimoto, H., Tanaka, H., Kanazawa, H., Hirata, K., Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 105:Apr (4) (2011), 519–525 PubMed PMID: 21041074.
75. El-Seify, M.Y., Fouda, E.M., Nabih, E.S., Serum level of soluble receptor for advanced glycation end products in asthmatic children and its correlation to severity and pulmonary functions. Clinical laboratory 60:6 (2014), 957–962 PubMed PMID: 25016700.
76. Bediwy, A.S., Hassan, S.M., El-Najjar, M.R., Receptor of advanced glycation end products in childhood asthma exacerbation. Egyptian Journal of Chest Diseases and Tuberculosis 65 (2016), 15–18.
77. Shim, E.J., Chun, E., Lee, H.S., Bang, B.R., Kim, T.W., Cho, S.H., et al. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clinical and Experimental Allergy: journal of the British Society for Allergy and Clinical Immunology 42:Jun (6) (2012), 958–965 PubMed PMID: 22909167.
78. Halayko, A.J., Ghavami, S., S100A8/A9: a mediator of severe asthma pathogenesis, morbidity?. Canadian journal of physiology, pharmacology 87:Oct (10) (2009), 743–755 PubMed PMID: 19898558.
79. Yang, Z., Yan, W.X., Cai, H., Tedla, N., Armishaw, C., Di Girolamo, N., et al. S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol 119:Jan (1) (2007), 106–114 PubMed PMID: 17208591.
80. Milutinovic, P.S., Alcorn, J.F., Englert, J.M., Crum, L.T., Oury, T.D., The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol 181:Oct (4) (2012), 1215–1225 PubMed PMID: 22889845. Pubmed Central PMCID: 3463633.
81. Ullah, M.A., Loh, Z., Gan, W.J., Zhang, V., Yang, H., Li, J.H., et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol 134:Aug (2) (2014), 440–450 PubMed PMID: 24506934.
82. Akirav, E.M., Henegariu, O., Preston-Hurlburt, P., Schmidt, A.M., Clynes, R., Herold, K.C., The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma. PLoS One, 9(4), 2014, e95678 PubMed PMID: 24759895. Pubmed Central PMCID: 3997417.
83. Oczypok, E.A., Milutinovic, P.S., Alcorn, J.F., Khare, A., Crum, L.T., Manni, M.L., et al. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol., 136(Sep (3)), 2015 747–56 e4. PubMed PMID: 25930197. Pubmed Central PMCID: 4562894.
84. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517:Jan (7534) (2015), 293–301 PubMed PMID: 25592534.
85. Kim, B.S., Artis, D., Group 2 Innate Lymphoid Cells in Health and Disease. Cold Spring Harbor perspectives in biology, 7(Jan (5)), 2015 PubMed PMID: 25573713.
86. Doherty, T.A., At the bench: understanding group 2 innate lymphoid cells in disease. Journal of leukocyte biology 97:Mar (3) (2015), 455–467 PubMed PMID: 25473099. Pubmed Central PMCID: 4338843.
87. Cayrol, C., Girard, J.P., IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 31:Dec (2014), 31–37 PubMed PMID: 25278425.
88. Lloyd, C.M., Saglani, S., Epithelial cytokines and pulmonary allergic inflammation. Curr Opin Immunol 34:Jun (2015), 52–58 PubMed PMID: 25705788.
89. Beucher, J., Boelle, P.Y., Busson, P.F., Muselet-Charlier, C., Clement, A., Corvol, H., et al. AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis. PLoS One, 7(7), 2012, e41913 PubMed PMID: 22860029. Pubmed Central PMCID: 3408394.
90. Iannitti, R.G., Casagrande, A., De Luca, A., Cunha, C., Sorci, G., Riuzzi, F., et al. Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis. Am J Respir Crit Care Med 188:Dec (11) (2013), 1338–1350 PubMed PMID: 24127697.
91. Makam, M., Diaz, D., Laval, J., Gernez, Y., Conrad, C.K., Dunn, C.E., et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A 106:Apr (14) (2009), 5779–5783 PubMed PMID: 19293384. Pubmed Central PMCID: 2667067.
92. Foell, D., Seeliger, S., Vogl, T., Koch, H.G., Maschek, H., Harms, E., et al. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 58:Jul (7) (2003), 613–617 PubMed PMID: 12832680. Pubmed Central PMCID: 1746749.
93. Reynolds, P.R., Schmitt, R.E., Kasteler, S.D., Sturrock, A., Sanders, K., Bierhaus, A., et al. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol 42:May (5) (2010), 545–551 PubMed PMID: 19541845.
94. Ramsgaard, L., Englert, J.M., Manni, M.L., Milutinovic, P.S., Gefter, J., Tobolewski, J., et al. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One., 6(5), 2011, e20132 PubMed PMID: 21629785. Pubmed Central PMCID: 3100338. Epub 2011/06/02. eng.
95. van Zoelen, M.A., Schouten, M., de Vos, A.F., Florquin, S., Meijers, J.C., Nawroth, P.P., et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 182:Apr (7) (2009), 4349–4356 PubMed PMID: 19299735.
96. Jabaudon, M., Blondonnet, R., Roszyk, L., Pereira, B., Guerin, R., Perbet, S., et al. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study. PLoS One, 10(8), 2015, e0135857 PubMed PMID: 26274928. Pubmed Central PMCID: 4537285.
97. Calfee, C.S., Ware, L.B., Eisner, M.D., Parsons, P.E., Thompson, B.T., Wickersham, N., et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63:Dec (12) (2008), 1083–1089 PubMed PMID: 18566109. Pubmed Central PMCID: 2764528.
98. Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Maeda, S., Yamagishi, S., Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem 44:Jun (8–9) (2011), 601–604 PubMed PMID: 21211520.
99. Patel, B.V., Wilson, M.R., Takata, M., Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J 39:May (5) (2012), 1162–1170 PubMed PMID: 22005920. Pubmed Central PMCID: 3568398.
100. Jabaudon, M., Blondonnet, R., Roszyk, L., Bouvier, D., Audard, J., Clairefond, G., et al. Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 192:Jul (2) (2015), 191–199 PubMed PMID: 25932660.
101. Baker, C.D., Alvira, C.M., Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Current opinion in pediatrics 26:Jun (3) (2014), 306–314 PubMed PMID: 24739494. Pubmed Central PMCID: 4121955.
102. Lizotte, P.P., Hanford, L.E., Enghild, J.J., Nozik-Grayck, E., Giles, B.L., Oury, T.D., Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol, 7, 2007, 15 PubMed PMID: 17343756. Pubmed Central PMCID: 1828052.
103. Reynolds, P.R., Stogsdill, J.A., Stogsdill, M.P., Heimann, N.B., Up-Regulation of RAGE by Alveolar Epithelium Influences Cytodifferentiation and Causes Severe Lung Hypoplasia. Am J Respir Cell Mol Biol(Jun), 2011 PubMed PMID: 21685154. Epub 2011/06/21. Eng.
104. Stogsdill, M.P., Stogsdill, J.A., Bodine, B.G., Fredrickson, A.C., Sefcik, T.L., Wood, T.T., et al. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol 49:Jul (1) (2013), 128–134 PubMed PMID: 23526218.
105. Aghai, Z.H., Saslow, J.G., Meniru, C., Porter, C., Eydelman, R., Bhat, V., et al. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy. Journal of perinatology: official journal of the California Perinatal Association 30:Sep (9) (2010), 610–615 PubMed PMID: 20182437.
106. Fan, L.L., Deterding, R.R., Langston, C., Pediatric interstitial lung disease revisited. Pediatric pulmonology 38:Nov (5) (2004), 369–378 PubMed PMID: 15376335.
107. Kurland, G., Deterding, R.R., Hagood, J.S., Young, L.R., Brody, A.S., Castile, R.G., et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 188:Aug (3) (2013), 376–394 PubMed PMID: 23905526. Pubmed Central PMCID: 3778735.
108. Soares, J.J., Deutsch, G.H., Moore, P.E., Fazili, M.F., Austin, E.D., Brown, R.F., et al. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics 132:Oct (4) (2013), 684–691 PubMed PMID: 24081995. Pubmed Central PMCID: 3784299.
109. Queisser, M.A., Kouri, F.M., Konigshoff, M., Wygrecka, M., Schubert, U., Eickelberg, O., et al. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 39:Sep (3) (2008), 337–345 PubMed PMID: 18421017.
110. Buckley, S.T., Medina, C., Kasper, M., Ehrhardt, C., Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 300:Apr (4) (2011), L548–L559 PubMed PMID: 21278261.
111. Bargagli, E., Penza, F., Bianchi, N., Olivieri, C., Bennett, D., Prasse, A., et al. Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis. Respir Physiol Neurobiol 165:Feb (2–3) (2009), 119–120 author reply 21–2. PubMed PMID: 19026768.
112. Konishi, K., Gibson, K.F., Lindell, K.O., Richards, T.J., Zhang, Y., Dhir, R., et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180:Jul (2) (2009), 167–175 PubMed PMID: 19363140. Pubmed Central PMCID: 2714820.
113. Ramsgaard, L., Englert, J.M., Tobolewski, J., Tomai, L., Fattman, C.L., Leme, A.S., et al. The role of the receptor for advanced glycation end-products in a murine model of silicosis. PLoS One, 5(3), 2010, e9604 PubMed PMID: 20333255. Pubmed Central PMCID: 2841632.
114. He, M., Kubo, H., Ishizawa, K., Hegab, A.E., Yamamoto, Y., Yamamoto, H., et al. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 293:dec (6) (2007), L1427–L1436 PubMed PMID: 17951314.
115. Englert, J.M., Kliment, C.R., Ramsgaard, L., Milutinovic, P.S., Crum, L., Tobolewski, J.M., et al. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis. Int J Clin Exp Pathol 4:Mar (3) (2011), 241–254 PubMed PMID: 21487520. Pubmed Central PMCID: 3071657. Epub 2011/04/14. eng.
116. Willis, B.C., Borok, Z., TGF-beta-induced EMT. mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293:Sep (3) (2007), L525–L534 PubMed PMID: 17631612.
117. Ding, H., Ji, X., Chen, R., Ma, T., Tang, Z., Fen, Y., et al. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 35:Dec (2015), 34–41 PubMed PMID: 26545872.
118. Arumugam, T., Simeone, D.M., Schmidt, A.M., Logsdon, C.D., S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279:Feb (7) (2004), 5059–5065 PubMed PMID: 14617629.
119. Rojas, A., Figueroa, H., Morales, E., Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis 31:Mar (3) (2010), 334–341 PubMed PMID: 20028726.
120. Schraml, P., Bendik, I., Ludwig, C.U., Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. Cancer Res 57:Sep (17) (1997), 3669–3671 PubMed PMID: 9288769.
121. Stav, D., Bar, I., Sandbank, J., Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int J Biol Markers 22:Apr–Jun (2) (2007), 108–113 PubMed PMID: 17549666.
122. Kalea, A.Z., See, F., Harja, E., Arriero, M., Schmidt, A.M., Hudson, B.I., Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res 70:Jul (13) (2010), 5628–5638 PubMed PMID: 20570900. Pubmed Central PMCID: 2919303.
123. Wang, H., Li, Y., Yu, W., Ma, L., Ji, X., Xiao, W., Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer. Oncology letters 10:Jul (1) (2015), 51–60 PubMed PMID: 26170976. Pubmed Central PMCID: 4487081.
124. Beer, D.G., Kardia, S.L., Huang, C.C., Giordano, T.J., Levin, A.M., Misek, D.E., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:Aug (8) (2002), 816–824 PubMed PMID: 1211244.
125. Diederichs, S., Bulk, E., Steffen, B., Ji, P., Tickenbrock, L., Lang, K., et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64:Aug (16) (2004), 5564–5569 PubMed PMID: 15313892.
126. Hsieh, H.L., Schafer, B.W., Sasaki, N., Heizmann, C.W., Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 307:Jul (2) (2003), 375–381 PubMed PMID: 12859967.
127. Miyazaki, N., Abe, Y., Oida, Y., Suemizu, H., Nishi, M., Yamazaki, H., et al. Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression. International Journal of Oncology 28:6 (2006), 1369–1374 PubMed PMID: 16685438.
128. Morbini, P., Villa, C., Campo, I., Zorzetto, M., Inghilleri, S., Luisetti, M., The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 19:Nov (11) (2006), 1437–1445 PubMed PMID: 16941014.
129. Sambamurthy, N., Leme, A.S., Oury, T.D., Shapiro, S.D., The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice. PLoS One, 10(3), 2015, e0118979 PubMed PMID: 25781626. Pubmed Central PMCID: 4364508.
130. Waseda, K., Miyahara, N., Taniguchi, A., Kurimoto, E., Ikeda, G., Koga, H., et al. Emphysema requires the receptor for advanced glycation end-products triggering on structural cells. Am J Respir Cell Mol Biol 52:Apr (4) (2015), 482–491 PubMed PMID: 25188021.
131. Reynolds, P.R., Kasteler, S.D., Schmitt, R.E., Hoidal, J.R., Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation. Am J Respir Cell Mol Biol 45:Aug (2) (2011), 411–418 PubMed PMID: 21131443.
132. Hou, C., Zhao, H., Liu, L., Li, W., Zhou, X., Lv, Y., et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17:7-8 (2011), 807–815 PubMed PMID: 21380479. Pubmed Central PMCID: 3146613.
133. Wu, L., Ma, L., Nicholson, L.F., Black, P.N., Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med 105:Mar (3) (2011), 329–336 PubMed PMID: 21112201.
134. Reimann, S., Fink, L., Wilhelm, J., Hoffmann, J., Bednorz, M., Seimetz, M., et al. Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema. Respiratory research, 16, 2015, 127 PubMed PMID: 26483185. Pubmed Central PMCID: 4612429.
135. Gopal, P., Reynaert, N.L., Scheijen, J.L., Schalkwijk, C.G., Franssen, F.M., Wouters, E.F., et al. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. Respiratory research, 15, 2014, 24 PubMed PMID: 24564838. Pubmed Central PMCID: 3944004.
136. Gopal, P., Rutten, E.P., Dentener, M.A., Wouters, E.F., Reynaert, N.L., Decreased plasma sRAGE levels in COPD: influence of oxygen therapy. Eur J Clin Invest 42:Aug (8) (2012), 807–814 PubMed PMID: 22288943.
137. Miniati, M., Monti, S., Basta, G., Cocci, F., Fornai, E., Bottai, M., Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respiratory research, 12, 2011, 37 PubMed PMID: 21450080. Pubmed Central PMCID: 3072955.
138. Iwamoto, H., Gao, J., Pulkkinen, V., Toljamo, T., Nieminen, P., Mazur, W., Soluble receptor for advanced glycation end-products and progression of airway disease. BMC pulmonary medicine, 14, 2014, 68 PubMed PMID: 24758342. Pubmed Central PMCID: 4021457.
139. Cheng, D.T., Kim, D.K., Cockayne, D.A., Belousov, A., Bitter, H., Cho, M.H., et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188:Oct (8) (2013), 948–957 PubMed PMID: 23947473.
140. Smith, D.J., Yerkovich, S.T., Towers, M.A., Carroll, M.L., Thomas, R., Upham, J.W., Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J 37:Mar (3) (2011), 516–522 PubMed PMID: 20595148.
141. Sukkar, M.B., Ullah, M.A., Gan, W.J., Wark, P.A., Chung, K.F., Hughes, J.M., et al. RAGE: a new frontier in chronic airways disease. British journal of pharmacology 167:Nov (6) (2012), 1161–1176 PubMed PMID: 22506507. Pubmed Central PMCID: 3504985.
142. Brusselle, G.G., Joos, G.F., Bracke, K.R., New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:Sep (9795) (2011), 1015–1026 PubMed PMID: 21907865.
143. Sparvero, L.J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med, 7, 2009, 17 PubMed PMID: 19292913. Pubmed Central PMCID: 2666642.
144. Farmer, D.G., Ewart, M.A., Mair, K.M., Kennedy, S., Soluble Receptor for Advanced Glycation End Products (sRAGE) Attenuates Haemodynamic Changes to Chronic Hypoxia in the Mouse. Pulm Pharmacol Ther(Jan), 2014 PubMed PMID: 24417910.
145. Tekabe, Y., Anthony, T., Li, Q., Ray, R., Rai, V., Zhang, G., et al. Treatment effect with anti-RAGE F(ab')2 antibody improves hind limb angiogenesis and blood flow in Type 1 diabetic mice with left femoral artery ligation. Vascular medicine(Mar), 2015 PubMed PMID: 25808570.
146. Brederson, J.D., Strakhova, M., Mills, C., Barlow, E., Meyer, A., Nimmrich, V., et al. A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse. European journal of pain 20:Apr (4) (2016), 607–614 PubMed PMID: 26392119.
147. Han, Y.T., Kim, K., Choi, G.I., An, H., Son, D., Kim, H., et al. Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE). European journal of medicinal chemistry 79:May (2014), 128–142 PubMed PMID: 24727489.
148. Deane, R., Singh, I., Sagare, A.P., Bell, R.D., Ross, N.T., LaRue, B., et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122:Apr (4) (2012), 1377–1392 PubMed PMID: 22406537. Pubmed Central PMCID: 3314449.
149. Christaki, E., Opal, S.M., Keith, J.C. Jr., Kessimian, N., Palardy, J.E., Parejo, N.A., et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock 35:May (5) (2011), 492–498 PubMed PMID: 21263385.
150. Burstein, A.H., Grimes, I., Galasko, D.R., Aisen, P.S., Sabbagh, M., Mjalli, A.M., Effect of TTP488 in patients with mild to moderate Alzheimer's disease. BMC neurology, 14, 2014, 12 PubMed PMID: 24423155. Pubmed Central PMCID: 4021072.
151. Walker, D., Lue, L.F., Paul, G., Patel, A., Sabbagh, M.N., Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease. Expert opinion on investigational drugs 24:Mar (3) (2015), 393–399 PubMed PMID: 25586103.